NATCO PHARMA
|
The Current P/E Ratio of NATCO PHARMA is 9.29.
Share Price | ₹976.8 | Jul 14,2025 |
Market Cap | ₹17,494.5 Cr | |
Earnings-TTM | ₹1,883.4 Cr | TTM-Consolidated Results |
Price/Earnings | 9.29x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of NATCO PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹17,494.5 Cr] as on Jul 14,2025
(/) Earnings [ ₹1,883.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 9.29x ]
Thus, for NATCO PHARMA , the investors are currently willing to pay 9.29 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NATCO PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NATCO PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of NATCO PHARMA
PE Ratio Performance Analysis for NATCO PHARMA
- NATCO PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 32.42x.
- NATCO PHARMA 's operated at median p/e ratio of 19.99x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NATCO PHARMA 's p/e ratio peaked in Mar2022 at 81.3x.
- NATCO PHARMA 's p/e ratio hit its five-year low in Mar2024 of 12.27x.
How does NATCO PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
NATCO PHARMA | 1,883.40 | 9.29 | 17,494.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.76 | 403,580.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.19 | 180,069.0 |
CIPLA LTD | 5,291.05 | 22.66 | 119,919.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 60.34 | 115,310.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.30 | 104,402.0 |
MANKIND PHARMA LTD | 2,003.22 | 55.62 | 111,429.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.12 | 97,453.8 |
LUPIN LTD | 3,306.26 | 26.59 | 87,906.4 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.82 | 66,141.7 |
ABBOTT INDIA LTD | 1,414.44 | 51.66 | 73,073.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NATCO PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 9.29x |
Max industry PE | 82.19x |
Median industry PE | 26.59x |
Average industry PE | 36.67x |
You may also like the below Video Courses